Home › NDC Lookup › Labelers › Loxo Oncology, Inc.

Loxo Oncology, Inc. NDCs and Package Codes

This page lists NDC package records associated with labeler code 71777 (Loxo Oncology, Inc.) — including active listings, ingredients, drug names, strengths, dosage forms, package sizes, pricing data when available, and links to each individual NDC page.

Key stats

3
Package NDCs
3
Products
3
Active listings
0
Discontinued
1
Ingredients
1
Therapeutic classes
2
Dosage forms
0
With NADAC pricing

Portfolio

By therapeutic class
ANTINEOPLASTIC SYSTEMIC ENZYME INH... 3
Top ingredients
LAROTRECTINIB 3
By dosage form
CAPSULE 2
SOLUTION 1

Browse records — 3 products

Drug / product Billing NDC NADAC / unit Status
VITRAKVI LAROTRECTINIB 25 mg/1 CAPSULE Loxo · NDC 71777-0390-01 · 60 CAPSULE in 1 BOTTLE (71777-390-01) 71777-0390-01 — On market View →
VITRAKVI LAROTRECTINIB 100 mg/1 CAPSULE Loxo · NDC 71777-0391-01 · 60 CAPSULE in 1 BOTTLE (71777-391-01) 71777-0391-01 — On market View →
VITRAKVI LAROTRECTINIB 20 mg/mL SOLUTION Loxo · NDC 71777-0392-01 · 100 mL in 1 BOTTLE (71777-392-01) 71777-0392-01 — On market View →
Where does this data come from?
NDC package records, ingredients, strengths and forms come from the openFDA NDC Directory, grouped by the 5-digit labeler code; pricing is CMS NADAC. This is a factual data directory, not a manufacturer marketing page.